Compositions and methods for the pulmonary delivery of aerosolized macromolecules
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-009/12
A61K-009/14
출원번호
US-0072430
(2002-02-08)
발명자
/ 주소
Platz, Robert M.
Patton, John S.
Foster, Linda
Eljamal, Mohammed
출원인 / 주소
Nektar Therapeutics
대리인 / 주소
Wilson Mark A.
인용정보
피인용 횟수 :
60인용 특허 :
136
초록▼
According to the subject invention, dispersible dry powder pharmaceutical-based compositions are provided, including methods for their manufacture and dry powder dispersion devices. A dispersible dry powder pharmaceutical-based composition is one having a moisture content of less than about 10% by w
According to the subject invention, dispersible dry powder pharmaceutical-based compositions are provided, including methods for their manufacture and dry powder dispersion devices. A dispersible dry powder pharmaceutical-based composition is one having a moisture content of less than about 10% by weight (% w) water, usually below about 5% w and preferably less than about 3% w; a particle size of about 1.0-5.0 μm mass median diameter (MMD), usually 1.0-4.0 μm MMD, and preferably 1.0-3.0 μm MMD; a delivered dose of about >30%, usually >40%, preferably >50%, and most preferred >60%; and an aerosol particle size distribution of about 1.0-5.0 μm mass median aerodynamic diameter (MMAD), usually 1.5-4.5 μm MMAD, and preferably 1.5-4.0 μm MMAD. Such compositions are of pharmaceutical grade purity.
대표청구항▼
1. An aerosolizable, spray-dried powder formulation for pulmonary delivery comprising a FSH, wherein the powder formulation (i) is substantially free of penetration enhancers, and (ii) comprises a plurality of particles having a particle size of less than 10 microns MMD wherein the formulation is fr
1. An aerosolizable, spray-dried powder formulation for pulmonary delivery comprising a FSH, wherein the powder formulation (i) is substantially free of penetration enhancers, and (ii) comprises a plurality of particles having a particle size of less than 10 microns MMD wherein the formulation is free of cyclodextrin with the provison that cyclodextrin is not in the formulation. 2. The formulation of claim 1, containing less than 5% FSH degradation products. 3. The formulation of claim 1, further comprising a pharmaceutically acceptable excipient. 4. The formulation of claim 3, wherein said excipient is selected from the group consisting of carbohydrates, amino acids, polypeptides, buffers, and salts. 5. The formulation of claim 4, wherein said excipient is a carbohydrate selected from the group consisting of galactose, mannose, sorbose, lactose, trehalose, raffinose, maltodextrins, dextrans, mannitol, and xylitol. 6. The formulation of claim 4, wherein said excipient is an amino acid. 7. The formulation of claim 6, wherein said amino acid is selected from the group consisting of alanine, glycine, tryptophan, tyrosine, leucine, and phenylalanine. 8. The formulation of claim 6, wherein said amino acid is a hydrophobic amino acid. 9. The formulation of claim 8, wherein said amino acid is effective to increase the dispersibility of the formulation. 10. The formulation of claim 4, wherein said excipient comprises HSA. 11. The formulation of claim 4, wherein said excipient comprises a buffer. 12. The formulation of claim 4, comprising from about 0.05 to about 99 percent by weight FSH. 13. The formulation of claim 1, particles sized from about 1.0-5.0 microns MMD. 14. The formulation of claim 1, wherein said powder comprises particles sized from about 1.0-5.0 microns MMAD. 15. The formulation of claim 1, further characterized by a delivered dose of greater than about 30%. 16. A method of treating a disease state responsive to treatment by FSH, said method comprising administering by inhalation to a subject in need thereof the formulation of claim 1 in aerosolized form. 17. The method of claim 16, wherein said administering step comprises dispersing said powder formulation in a gas stream to form an aerosol and inhaling. 18. A method for preparing a FSH dry powder composition suitable for pulmonary delivery, said method comprising spray drying an aqueous mixture comprising FSH under conditions effective to provide a respirable, spray dried FSH powder, wherein the powder formulation (i) is substantially free of penetration enhancers, and (ii) comprises a plurality of particles having a particle size of less than 10 microns MMD wherein the formulations is free of cyclodextrin. 19. The method of claim 18, wherein the powder formed in said spray drying step contains less than 5% FSH degradation products. 20. The method of claim 18, wherein said aqueous mixture further comprises a pharmaceutically acceptable excipient. 21. The method of claim 18, wherein 98% or more of the mass of the spray dried powder comprises particles having a diameter of 10 microns or less. 22. The method of claim 18 wherein 90% or more of the mass of the spray dried powder comprises particles having a diameter of 5 microns or less.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (136)
Dunlap Richard P. (Penfield NY) Hlasta Dennis J. (Clifton Park NY) Desai Ranjit C. (Colonie NY) Latimer Lee H. (Brighton NY) Subramanyam Chakrapani (East Greenbush NY) Court John J. (Colonie NY) Bell, 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use.
Evans Richard M. (Westwood MA) Farr Stephen J. (Llandaf GB7), Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol.
Arora Vijay K. (Montvale NJ) Jones Gary V. (Bremen NJ DEX) Kovtun John M. (Rahway NJ) Brandlein Lawrence S. (Englishtown NJ), Coffee flakes and process.
Wang Yu-chang J. (Los Altos CA) Lee William A. (Los Altos CA) Narog Blair (Palo Alto CA), Composition and method for administration of pharmaceutically active substances.
Carpenter John F. (David CA) Hand Steven C. (Louisville CO) Crowe Lois M. (Davis CA) Crowe John H. (Davis CA), Cryogenic protection of phosphofructokinase using amino acids and zinc ions.
Andersson Jan A. R. (S. Sandby SEX) Nilsson Nils G. (Lund SEX) Fagerstrm Per-Olof S. (Bjrred SEX) Wendel Thomas M. (Genarp SEX), Device in connection with an inhaler.
Newell Robert E. (Pinner GB2) Rand Paul K. (Nitchin GB2) Fitzsimmons Robert A. (Barnard Castle GB2), Devices for administering medicaments to patients.
Platz Robert M. ; Patton John S. ; Foster Linda C. ; Eljamal Mohammed,LBX, Dispersible antibody compositions and methods for their preparation and use.
Cohen Smadar (Petach-Tickva ILX) Bano Carmen (Valencia PA ESX) Visscher Karyn B. (State College PA) Chow Marie (Brookline MA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Ionically cross-linked polymeric microcapsules.
Chien Yie W. (North Brunswick NJ) Kong-Jiann Li John (Plainsboro NJ) Liu Jue-Chen (East Brunswick NJ) Shi Wei-Min (Piscataway NJ) Siddiqui Ovais (Piscataway NJ) Sun Ying (King of Prussia PA), Iontotherapeutic device and process and iontotherapeutic unit dose.
Zoltan Bart J. (Old Tappan NJ) Laube Beth L. (Baltimore MD) Adams ; III George K. (Baltimore MD) Bow Clark F. (Newton NJ) Devito Ralph J. (Stanhope NJ) Harrington Walter (Flanders NJ) Hoffman Louis S, Medication delivery system phase two.
Smith Adrian E. ; Burr John D. ; Etter Jeffery W. ; Axford George S. ; Lyons Shirley W. ; Platz Robert M., Method and apparatus for dispersion of dry powder medicaments.
Platz Robert M. ; Kimura Shigenobu,JPX ; Satoh Yu-ichiro,JPX ; Foster Linda C., Methods and compositions for the dry powder formulation of interferons.
Boyes Robert N. (St. Albans AL GB2) Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL) Pledger Kenneth L. (Huntsville AL), Pharmaceutical formulations comprising microcapsules.
Brenner Joseph (Middletown NY) Henderson Gary H. (Middletown NY) Bergensten Robert W. (Kerhonkson NY), Process of encapsulating an oil and product produced thereby.
Backstrom Kjell Goran Erik,SEX ; Dahlback Carl Magnus Olof,SEX ; Edman Peter,SEX ; Johansson Ann Charlotte Birgit,SEX, Processes for preparing compositions for inhalation.
Sarin Virender K. (Libertyville IL) Fox Jack L. (Lake Bluff IL) Gupta Shanker L. (Vernon Hills IL) Absolom Darryl R. (Columbus OH), Pulmonary surfactant protein fragments.
Hlasta Dennis J. (Lower Salford Township ; Montgomery County PA) Ackerman James H. (Albany NY) Mura Albert J. (Rochester NY) Desai Ranjit C. (Towamencin Township ; Montgomery County PA), Saccharin derivative proteolytic enzyme inhibitors.
Knight Jack V. (Houston TX) Wilson ; Jr. Samuel Z. (Houston TX), Small particle aerosol generator for treatment of respiratory disease including the lungs.
Knight Jack V. (Houston TX) Gilbert Brian E. (Houston TX) Wilson Samuel Z. (Houston TX) Six Howard R. (East Stroudsborg PA) Wyde Philip R. (Houston TX), Small particle aerosol liposome and liposome-drug combinations for medical use.
Dower Steven K. (Redmond WA) March Carl J. (Bainbridge Island WA) Sims John E. (Seattle WA) Urdal David L. (Seattle WA), Soluble human interleukin-1 receptors, compositions and method of use.
Bokovi Marijan A. (Ridgefield CT) Vidal Susan M. (Patterson NY) Saleeb Fouad Z. (Pleasantville NY), Spray-dried fixed flavorants in a carbohydrate substrate and process.
Feldman Fred (Park Forest IL) Klekamp Mark S. (Bourbonnais IL) Hrinda Michael E. (Gwynedd Valley PA) Shaw Arthur B. (Audubon PA) Chandra Sudhish (Kankakee IL), Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants.
Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Systemic administration of a therapeutic preparation.
Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Therapeutic preparation for inhalation.
Sakon Kiyoyuki,JPX ; Sakagami Masahiro,JPX ; Makino Yuji,JPX ; Suzuki Yoshiki,JPX ; Kobayashi Hideki,JPX, Ultrafine particle power for inhalation and method for production thereof.
Adamo, Benoit; Polidoro, John M.; Overfield, Dennis; Sahi, Carl R.; Laurenzi, Brendan; Smutney, Chad C.; Kinsey, P. Spencer, Apparatus and method for simulating inhalation efforts.
Smutney, Chad C.; Adamo, Benoit; Polidoro, John M.; Kinsey, P. Spencer; Overfield, Dennis; Sahi, Carl; Billings, Christine; Marino, Mark T., Dry powder drug delivery system and methods.
Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony; He, Tom; Mann, Alfred, Dry powder inhaler and system for drug delivery.
Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfiled, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
Tarara, Thomas E.; Weers, Jeffry G.; Eldon, Michael A.; Narashimhan, Rangachari; Clark, Andrew, Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use.
Smutney, Chad C.; Leone-Bay, Andrea; Galarza, Jose M.; Munoz, Hector; Martin, George R.; Grant, Marshall L., Inhalable vaccine compositions and methods.
Oberg, Keith A.; Sulner, Joseph; Grant, Marshall L., Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents.
Tarara, Thomas E.; Weers, Jeffrey G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Pulmonary delivery particles comprising an active agent.
Dellamary, Luis A.; Reiss, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery.
Dellamary, Luis A.; Riess, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
Dellamary, Luis A; Riess, Jean; Schutt, Ernest G; Weers, Jeffry G; Tarara, Thomas E, Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.